Contact
Please use this form to send email to PR contact of this press release:
Supernus Receives FDA Tentative Approval for Expanded Label of Trokendi XR® to Include Migraine Prophylaxis in Adults
TO:
Please use this form to send email to PR contact of this press release:
Supernus Receives FDA Tentative Approval for Expanded Label of Trokendi XR® to Include Migraine Prophylaxis in Adults
TO: